Tag Archive | "Merck"

Merck and Tetralogic in solid tumor clinical pact

Tags: , ,


TetraLogic and Merck will collaborate on a Phase 1 study Read the full story

Merck and Arvinas in therapy alliance using Protac technology

Tags: , ,


Arvinas announced a strategic collaboration with Merck in which Arvinas’ novel PROTAC technology will be used to degrade target proteins, with the goal of creating novel therapeutics Read the full story

Merck and Syndax partner for cancer combo clinical

Tags: , ,


Syndax and Merck have entered into a clinical trial collaboration to evaluate the safety and efficacy of combining entinostat, an investigational epigenetic therapy, with KEYTRUDA Read the full story

Eisai and Merck in solid tumour triple therapy pact

Tags: , , ,


Eisai and Merck announced a clinical trial collaboration to evaluate the safety, tolerability and efficacy of Merck’s anti-PD-1 therapy, pembrolizumab Read the full story

Merck and NGM collaborate on biologic therapies

Tags: , ,


NGM Biopharmaceuticals and Merck have entered into a multi-year collaboration to research, discover, develop and commercialize novel biologic therapies across a wide range of therapeutic areas Read the full story

Merck licenses Moderna’s RNA-based antiviral vaccines and passive immunity therapies

Tags: , ,


Moderna Therapeutics announced a license and collaboration agreement with Merck for the discovery and development of vaccines and passive immunity treatments against viral diseases Read the full story

Eli Lilly and Merck study Keytruda combinations

Tags: , , ,


Merck and Eli Lilly announced an oncology clinical trial collaboration to evaluate the safety, tolerability and efficacy of KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with Lilly compounds in multiple clinical trials Read the full story

Merck and Enumeral predicting clinical drug response

Tags: ,


Enumeral Biomedical has signed an oncology-focused collaborative study agreement with Merck Read the full story

Merck acquires OncoEthix, gains OTX015

Tags: , ,


Merck has acquired OncoEthix Read the full story

Merck and Newlink ink Ebola vaccine deal

Tags: , , ,


Merck and NewLink Genetics have entered into an exclusive worldwide license agreement to research, develop, manufacture, and distribute NewLink's investigational rVSV-EBOV (Ebola) vaccine candidate Read the full story